Eddit
| Zeile 3: | Zeile 3: | ||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
| − | |||
*'''[[Reviews on covid19 disease]]''' | *'''[[Reviews on covid19 disease]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Diagnosis (other modalities)]]''' | *'''[[Diagnosis (other modalities)]]''' | ||
| − | |||
| − | |||
| − | |||
| Zeile 71: | Zeile 24: | ||
*'''[[Structure of covid19]]''' | *'''[[Structure of covid19]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
| Zeile 91: | Zeile 36: | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 109: | Zeile 44: | ||
---- | ---- | ||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 118: | Zeile 49: | ||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
| − | |||
| − | |||
---- | ---- | ||
| Zeile 128: | Zeile 57: | ||
*'''[[Systemic disease, any manifestations]]''' | *'''[[Systemic disease, any manifestations]]''' | ||
*'''[[Co-Infection]]''' | *'''[[Co-Infection]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[ARDS]]''' | *'''[[ARDS]]''' | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 150: | Zeile 67: | ||
*'''[[Heart]]''' | *'''[[Heart]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Neurology, ophthalmology, orl]]''' | *'''[[Neurology, ophthalmology, orl]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
{{tp|p=32341078|t=2020. COVID-19 patients presenting with afebrile acute abdominal pain |pdf=|usr=}} | {{tp|p=32341078|t=2020. COVID-19 patients presenting with afebrile acute abdominal pain |pdf=|usr=}} | ||
Version vom 1. Juni 2020, 13:36 Uhr
32341078 2020. COVID-19 patients presenting with afebrile acute abdominal pain
32253163 2020. The occurrence of diarrhea in COVID-19 patients
| 32314455 2020. COVID-19 infection may cause ketosis and ketoacidosis |
32349002 2020. COVID-19: Don`t neglect the Gastrointestinal Tract!
32335962 2020. COVID-19 and gastrointestinal endoscopy: what should be taken into account?
32335946 2020. Gastrointestinal endoscopy in the era of the acute pandemic of coronavirus disease 2019: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9th, 2020)
32281689 2020. COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies
32234303 2020. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 and Coronavirus Disease 2019
32327413 2020. Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
32377468 ä. First Case of an Infant with COVID-19 in the Middle East
32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32282224 2020. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations
32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)
32286246 2020. COVID-19 infections are also affected by human ACE1 D/I polymorphism
32112082 2020. A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load
32220930 2020. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
32342637 2020. COVID-19 and obesity
32292054 2020. SARS-CoV-2 Infection in a 2-Week-Old Male With Neutropenia
32255491 2020. ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19
32320478 2020. Risks of ACE Inhibitor and ARB Usage in COVID-19: Evaluating the Evidence
32237261 ä. The COVID?19 outbreak and rheumatologic skin diseases
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?
32375909 ä. Impact of Fundamental Diseases on Patients With COVID-19
32129518 ä. Angiotensin receptor blockers as tentative SARS?CoV?2 therapeutics
32233013 ä. Diabetes is a risk factor for the progression and prognosis of COVID?19
32374012 2020. Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries
32189428 ä. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID?19 in the general population?
32376408 ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
32356577 2020. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration
32359088 2020. RAAS blockers in hypertension posing a higher risk towards the COVID-19
32362061 2020. (pat.on)Dupilumab and COVID-19: What should we expect?
32259611 2020. COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
32356926 2020. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19
32304146 2020. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections
32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR
32234728 2020. EMA advice on the use of NSAIDs for Covid-19
32295811 2020. EMA advice on renin-angiotensin system medicines during covid-19 pandemic
32357072 2020. CLINICAL CHARACTERISTICS OF 28 PATIENTS WITH DIABETES AND COVID-19 IN WUHAN, CHINA
32376075 2020. Oligohydramnion in COVID19
32290680 2020. Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
32310915 2020. ACE-inibitori, sartani e sindrome respiratoria acuta da coronavirus 2
32354990 2020. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19
32362297 ä. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
32234453 2020. Follow-up of asymptomatic patients with SARS-CoV-2 infection
32248675 2020. Critically ill patients with COVID-19 in Hong Kong: a multicentre retrospective observational cohort study
32378503 ä. Lessons Learned From Cases of COVID-19 Infection in South Korea
32352401 2020. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States
32314503 2020. Obesity and SARS-CoV-2: a population to safeguard
32273181 2020. COVID-19 in a Kidney Transplant Patient
32249089 2020. Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
32379692 ä. Traditional Chinese Medicine treatment of COVID-19
32379639 2020. Herbal medicine for treatment of children diagnosed with COVID-19: A review of guidelines
| 32271624 2020. Will Complement Inhibition be the New Target in Treating COVID-19 Related Systemic Thrombosis? |
32333649 2020. The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene
32378737 2020. The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
32356569 2020. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology
32246834 2020. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection
32350860 2020. Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2
32348551 2020. Response to: Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing: Quantitative Clinical Pharmacology Input to SARS-CoV-2 Therapeutics Should Be Based on Robust Data
32302411 2020. Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19
32167153 2020. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
32345063 2020. Truncated IV acetylcysteine treatment duration has potential to safely preserve resources during the COVID-19 pandemic
32315229 2020. COVID-19 and the CRISPR Community Response
32321407 2020. Hispidin and Lepidine E: two Natural Compounds and Folic acid as Potential Inhibitors of 2019-novel coronavirus Main Protease (2019-nCoVMpro), molecular docking and SAR study
| 32297571 2020. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus |
32334502 2020. The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
32133962 2020. Effective Chemicals against Novel Coronavirus (COVID-19) in China
32314492 ä. Doxycycline, a widely used antibiotic in dermatology with a possible anti?inflammatory action against IL?6 in COVID?19 outbreak
32237190 ä. What does androgenetic alopecia have to do with COVID?19? An insight into a potential new therapy
32227357 ä. COVID?19 treatment by repurposing drugs until the vaccine is in sight
32377559 ä. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus
32374010 2020. Are probiotics effective adjuvant therapeutic choice in patients with COVID-19?
32374009 2020. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19
32369103 ä. Sacubitril/valsartan in COVID-19 patients: the need for trials
32373994 2020. Could host cell receptor alteration prevent SARS-CoV-2 viral entry? - Hype or hope
32373992 2020. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment
32373991 2020. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking
32362193 2020. Quadruple therapy for asymptomatic COVID-19 infection patients
32366131 2020. Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine
32336007 2020. DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?
32224164 2020. COVID-19 and diabetes: Can DPP4 inhibition play a role?
32278585 2020. Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
| 32337769 2020. (tt bradykinin) Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2 |
32352361 2020. Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists
32359101 2020. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications
32281695 2020. Existing bitter medicines for fighting 2019-nCoV-associated infectious diseases
32379896 2020. Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs
31690127 2019. Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach
32157732 ä. Harnessing the immune system via Fc?R function in immune therapy: a pathway to next?gen mAbs
32369619 2020. Observations about sexual and other routes of SARS-CoV-2 (COVID-19) transmission and its prevention
32277746 2020. Fecal Shedding of SARS CoV-2: Implications for Disease Spread and Quarantine
32170800 ä. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health?care workers fighting against coronavirus disease 2019
32216640 2020. CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic
32200663 2020. COVID-19 and Cardiovascular Disease
32312892 2020. Adapting to a Pandemic - Conducting Oncology Trials during the SARS-CoV-2 Pandemic
32245780 2020. COVID-19 and the Inpatient Dialysis Unit: Managing Resources during Contingency Planning Pre-Crisis
32241778 2020. Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis
32222700 2020. On the Frontline of the COVID-19 Outbreak: Keeping Patients on Long-Term Dialysis Safe
32198130 2020. Mitigating Risk of COVID-19 in Dialysis Facilities
32345750 2020. Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients
32345749 2020. Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic
32332048 2020. How COVID-19 Has Changed the Management of Glomerular Diseases
32358234 2020. The American College of Nuclear Medicine Guidance on Operating Procedures for a Nuclear Medicine Facility During COVID-19 Pandemic
32324943 2020. How to manage smoke evacuation and filter pneumoperitoneum during laparoscopy to minimize potential viral spread: different methods from SoMe - a video vignette
32356955 2020. Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction
32275124 2020. Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm
32358977 2020. New clinical needs and strategies for care in children with neurodisability during COVID-19
32319209 2020. Challenge of managing patients with COVID-19 and acute behavioural disturbances
32295770 2020. Swivel-HEPA-ETT (SHE) bougie and HEPA-ETT (HE) methods for safe intubation while managing patients with COVID-19
32259419 2020. Calculated decisions: COVID-19 calculators during extreme resource-limited situations
32375190 2020. Endoscopic ultrasound-guided gallbladder drainage as a strategy to overcome shortage of operating rooms and intensive care unit beds during Covid-19 crisis
32380475 2020. Endocrinology in the time of COVID-19: Management of Cushing s syndrome
32369770 2020. Endocrinology in the time of COVID-19: Management of pituitary tumours
32380474 2020. Endocrinology in the time of COVID-19: Management of Hyponatraemia and Diabetes Insipidus
32379699 2020. Endocrinology in the time of COVID-19: Management of adrenal insufficiency
32352362 2020. Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China
32281754 2020. Managing patients in dialysis and with kidney transplant infected with Covid-19
32281757 2020. Covid-19 in patients on dialysis: infection prevention and control strategies
32372736 ä. Wearing face masks regardless of symptoms is crucial for preventing the spread of COVID-19 in hospitals
32377486 ä. How Essential Is to Focus on Physician s Health and Burnout in Coronavirus (COVID-19) Pandemic?
32267243 2020. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)
32349837 ä. COVID-19: the implications for suicide in older adults
32376695 2020. Where have all the children gone? Decreases in paediatric emergency department attendances at the start of the COVID-19 pandemic of 2020
32366503 2020. Covid-19: NHS bosses told to assess risk to ethnic minority staff who may be at greater risk
32366510 2020. Covid-19: collateral damage of lockdown in India
32253178 2020. Covid-19 and the rise of racism
32196426 2020. Seasonality of Respiratory Viral Infections
32351197 2020. COVID-19 is possibly a consequence of the anthropogenic biodiversity crisis and climate changes
32276290 ä. COVID?19: A relationship to climate and environmental conditions?
32373996 2020. The correlation between the spread of COVID-19 infections and weather variables in 30 Chinese provinces and the impact of Chinese government mitigation plans
32186951 2020. One Health approach and Coronavirus Disease 2019
32373995 2020. Bioinformatic analysis indicates that SARS-CoV-2 is unrelated to known artificial coronaviruses
32364762 2020. At the Heart of the Matter: Unmasking and Addressing COVID-19 s Toll on Diverse Populations
32221515 2020. Spotlight on Jails: COVID-19 Mitigation Policies Needed Now
| 32267544 2020. Quarantine alone or in combination with other public health measures to control COVID?19: a rapid review |
32367739 2020. Outbreak dynamics of COVID-19 in Europe and the effect of travel restrictions
32187421 ä. COVID?19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?
32170898 ä. COVID?19 and rationally layered social distancing
32377056 ä. Lockdown?the only solution to defeat COVID-19
32366742 ä. Prolonged Viral RNA Shedding Duration in COVID-19
32342849 2020. Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19)
32297851 ä. Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China
32324421 2020. Raids on Immigrant Communities During the Pandemic Threaten the Country s Public Health
32366370 2020. Covid-19: Coroners needn t investigate PPE policy failures in deaths of NHS staff, new guidance says
32227594 ä. Social media for rapid knowledge dissemination: early experience from the COVID?19 pandemic
32213480 2020. Covid-19: how to be careful with trust and expertise on social media
32374013 2020. Faced with 2019-nCoV outbreak, we have learned our lessons from SARS of 2003
32374011 2020. Herd immunity and COVID-19
32202659 2020. Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures
32376793 2020. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
32355114 2020. Improper use of germicidal range ultraviolet lamp for household disinfection leading to phototoxicity in COVID-19 suspects
32302975 2020. Androgen hazards with COVID-19
32279694 ä. Covid-19 and the N95 respirator shortage: Closing the gap
